These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32189379)

  • 1. Novel mutation in the KITLG gene in familial progressive hyperpigmentation with or without hypopigmentation.
    Kato M; Yagami A; Tsukamoto T; Shinkai Y; Kato T; Kurahashi H
    J Dermatol; 2020 Jun; 47(6):669-672. PubMed ID: 32189379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel mutation in the KITLG gene in a Chinese family with familial progressive hyper- and hypopigmentation.
    Wang J; Li W; Zhou N; Liu J; Zhang S; Li X; Li Z; Yang Z; Sun M; Li M
    BMC Med Genomics; 2021 Jan; 14(1):12. PubMed ID: 33407466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo mutation in KITLG gene causes a variant of Familial Progressive Hyper- and Hypo-pigmentation (FPHH).
    Gorenjak M; Fijačko N; Bogomir Marko P; Živanović M; Potočnik U
    Mol Genet Genomic Med; 2021 Dec; 9(12):e1841. PubMed ID: 34716665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KITLG mutations cause familial progressive hyper- and hypopigmentation.
    Amyere M; Vogt T; Hoo J; Brandrup F; Bygum A; Boon L; Vikkula M
    J Invest Dermatol; 2011 Jun; 131(6):1234-9. PubMed ID: 21368769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Report of a child with sporadic familial progressive hyper- and hypopigmentation caused by a novel KITLG mutation.
    Zhang J; Cheng R; Liang J; Ni C; Li M; Yao Z
    Br J Dermatol; 2016 Dec; 175(6):1369-1371. PubMed ID: 27106731
    [No Abstract]   [Full Text] [Related]  

  • 6. Familial progressive hyper- and hypopigmentation and malignancy in two families with new mutations in KITLG.
    Cuell A; Bansal N; Cole T; Kaur MR; Lee J; Loffeld A; Moss C; O'Donnell M; Takeichi T; Thind CK; McGrath JA
    Clin Exp Dermatol; 2015 Dec; 40(8):860-4. PubMed ID: 26179221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial progressive hyper- and hypopigmentation: a report on a Chinese family and evidence for genetic heterogeneity.
    Xiao-Kai F; Yue-Xi H; Yan-Jia L; Li-Rong C; He-Peng W; Qing S
    An Bras Dermatol; 2017; 92(3):329-333. PubMed ID: 29186243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial progressive hyper- and hypopigmentation caused by a novel mutation in site II of the KITLG gene.
    Liu Z; Zhu Z; Luo J; Yang B
    J Dermatol; 2021 Sep; 48(9):e462-e463. PubMed ID: 34114687
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical phenotype and genetic analysis of a Chinese pedigree affected with familial progressive hyperpigmentation and hypopigmentation].
    Xu Z; Su Z; Zheng R; Hou L; Zhang L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Dec; 39(12):1360-1365. PubMed ID: 36453959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial progressive hypo- and hyperpigmentation: a variant case.
    Zhang RZ; Zhu WY
    Indian J Dermatol Venereol Leprol; 2012; 78(3):350-3. PubMed ID: 22565436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetic determination of skin pigmentation: KITLG and the KITLG/c-Kit pathway as key players in the onset of human familial pigmentary diseases.
    Picardo M; Cardinali G
    J Invest Dermatol; 2011 Jun; 131(6):1182-5. PubMed ID: 21566575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloidosis cutis dyschromica cases caused by GPNMB mutations with different inheritance patterns.
    Qin W; Wang H; Zhong W; Bai J; Qiao J; Lin Z
    J Dermatol Sci; 2021 Oct; 104(1):48-54. PubMed ID: 34551863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial progressive hyperpigmentation and hypopigmentation without KITLG mutation.
    Zeng L; Zheng XD; Liu LH; Fu LY; Zuo XB; Chen G; Wang PG; Yang S; Zhang XJ
    Clin Exp Dermatol; 2016 Dec; 41(8):927-929. PubMed ID: 27859606
    [No Abstract]   [Full Text] [Related]  

  • 14. A case of familial progressive hyperpigmentation with or without hypopigmentation presenting with hypopigmented striae along the lines of Blaschko.
    Hida T; Idogawa M; Ishikawa A; Okura M; Sasaki S; Tokino T; Uhara H
    J Dermatol; 2024 Sep; ():. PubMed ID: 39269165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial hyper- and hypopigmentation with age-related pattern change.
    Hoo JJ; Shrimpton AE
    Am J Med Genet A; 2005 Jan; 132A(2):215-8. PubMed ID: 15551335
    [No Abstract]   [Full Text] [Related]  

  • 16. Familial reticulate acropigmentation of Dohi: a case report.
    Obieta MP
    Dermatol Online J; 2006 Mar; 12(3):16. PubMed ID: 16638430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biallelic KITLG variants lead to a distinct spectrum of hypomelanosis and sensorineural hearing loss.
    Vona B; Schwartzbaum DA; Rodriguez AA; Lewis SS; Toosi MB; Radhakrishnan P; Bozan N; Akın R; Doosti M; Manju R; Duman D; Sineni CJ; Nampoothiri S; Karimiani EG; Houlden H; Bademci G; Tekin M; Girisha KM; Maroofian R; Douzgou S
    J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):1606-1611. PubMed ID: 35543077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gain-of-function mutation of KIT ligand on melanin synthesis causes familial progressive hyperpigmentation.
    Wang ZQ; Si L; Tang Q; Lin D; Fu Z; Zhang J; Cui B; Zhu Y; Kong X; Deng M; Xia Y; Xu H; Le W; Hu L; Kong X
    Am J Hum Genet; 2009 May; 84(5):672-7. PubMed ID: 19375057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generalized Dowling-Degos disease.
    Wu YH; Lin YC
    J Am Acad Dermatol; 2007 Aug; 57(2):327-34. PubMed ID: 17637446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four novel mutations of the ADAR1 gene in dyschromatosis symmetrica hereditaria.
    Murata I; Hozumi Y; Kawaguchi M; Katagiri Y; Yasumoto S; Kubo Y; Fujimoto W; Horikawa T; Kondo T; Kono M; Tomita Y; Suzuki T
    J Dermatol Sci; 2009 Jan; 53(1):76-7. PubMed ID: 18799292
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.